Kits

Tissue Repair Pair (BPC-157 + TB-500)

BPC-157 and TB-500 as separate 10mg vials with water, forty syringes and swabs. In Stock

What is in the kit

Why this kit

Separate vials rather than the blend, for designs that vary the ratio; 2 mL each.

Kit value

Bought separately the 5 items come to $287.75. The kit is $255.99, which saves $31.76 (11%). Every item is the same product sold on its own page, from the same Australian stock, with a certificate of analysis available for each peptide batch.

Preparing the kit

1. Reconstitute BPC-157 (10mg). Add 2 mL of bacteriostatic water slowly down the inside wall of the vial and swirl gently until clear; do not shake. 10mg in 2 mL gives 5 mg/mL. The calculator has this vial preset.
2. Reconstitute TB-500 (10mg). Add 2 mL of bacteriostatic water slowly down the inside wall of the vial and swirl gently until clear; do not shake. 10mg in 2 mL gives 5 mg/mL. The calculator has this vial preset.
3. Draw and swab. Swab the vial stopper before each draw. Use a fresh U-100 syringe each time; the calculator converts the amount in milligrams to syringe units at the concentration prepared.
4. Store. Lyophilised vials at −20 °C until reconstitution. Reconstituted solution and pens at 2–8 °C, never frozen; reconstituted vials are used within 8–12 weeks, opened bacteriostatic water within 28 days.

About BPC-157 and TB-500

BPC-157

Synthetic pentadecapeptide derived from a gastric protein sequence

A stable sequence of 15 amino acids lifted from a protective protein in human gastric juice, BPC-157 ranks among the most heavily cited repair peptides in the preclinical record. Several hundred rodent experiments have examined it across tendon, ligament, muscle, gut and nervous-system injury. Part of what sets it apart is its durability: it withstands stomach acid and stays active in solution for days.

Accelerated healing against controls has been reported in rat Achilles tendon transection (Staresinic et al., J Orthop Res 2003), medial collateral ligament injury, muscle crush and gastric-ulcer models. Gut work shows the intestinal lining protected in NSAID-induced injury. The human record is thin, limited to small trials and case series, and no controlled human trial exists.

BPC-157 in Australia: sizes, research summary and legal status →

TB-500

Synthetic fragment of thymosin beta-4 (residues 17-23 region)

TB-500 is a short synthetic peptide that reproduces the actin-binding region of thymosin beta-4, a 43-amino-acid protein found in nearly every human cell. Thymosin beta-4 governs actin polymerisation, the machinery cells use to move, and it is that property the bulk of the repair research leans on.

Thymosin beta-4 has been examined in dermal wound healing (Malinda et al., J Invest Dermatol 1999), corneal injury, and cardiac repair after infarction in mouse models (Bock-Marquette et al., Nature 2004). Clinical trials of the full-length protein in venous ulcers and dry eye have been completed, while the synthetic fragment itself remains at the preclinical stage.

TB-500 in Australia: sizes, research summary and legal status →

Certificate of analysis. Every peptide in the kit comes from a batch with a certificate from an independent laboratory. Request the certificate for your batch with your order number.

For in-vitro research and laboratory use only. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher and will use these products in accordance with all applicable laws.